Circulating EPCs were significantly increased after rosuvastatin treatment ( from 230 ( 170-380 ) and 10 ( 8-24 ) to 390 ( 230-520 ) and 19 ( 8-33 ) cells/10 ( 6 ) lymphomonocytes , respectively , p = 0.004 and p = 0.008 ) , whereas they remained unchanged in the other groups .
